Molecular Mechanisms and Treatments on Musculoskeletal Disorders
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 3335
Special Issue Editors
Interests: osteoporosis; sarcopenia; osteogenesis; osteoclastogenesis; sports medicine
2. Department of Orthopedics, Taipei Medical University Hospital, Taipei 11031, Taiwan
3. TMU Biodesign Center, Taipei Medical University, Taipei 11031, Taiwan
Interests: orthopedics; osteoporosis; medicine chemistry biochemistry, genetics and molecular biology；biodesign; pain management; spinal disorder; medical device; clinical trial
Special Issue Information
Dear colleagues,
Geriatric medicine is more emphasized in the decade because of a serious public problem in the whole world, population aging. With the age, multiple organ systems are going to functional decline such as the brain, heart, nerves, and musculoskeletal system, etc. Especially, the decline of the musculoskeletal system will have a high risk to impair daily activity. The sequela of sarcopenia may result in the impairment of physical activity or an increase in fall risk. Osteoporosis results in bone fragility and increases the risk of fractures. In addition, osteoporotic fractures increase mortality, morbidity, and chronic pain. Most osteoporotic fractures resulted from falls. Approximately 35% to 45% of people aged 65 or older fall at least once a year, and the occurrence of falls increases in frequency and severity in older adults. The decrease in the capacity of independent living and health-related quality of life, resulting from musculoskeletal system disorder, make the subsequent high health care costs. Therefore, figuring out the molecular mechanisms of the musculoskeletal system and developing treatments for musculoskeletal disorders are very important in the aging society.
Dr. Wei-Bin Hsu
Dr. Meng-Huang Wu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- osteoporosis
- sarcopenia
- osteoblast
- osteoclast
- myoblast
- satellite cell
